Faculty Scholars

Faculty Scholar Charles D. Rice, Ph.D. at Clemson University, Clemson South Carolina

Charles D. Rice, Ph.D.

Department of Biological Sciences
College of Science

Contact: 864-508-0710 or cdrice@clemson.edu

Who is Dr. Rice?

Charles Rice received his B.S. in Biology Education at Virginia Commonwealth University, followed by a M.S. in Biology, also from Virginia Commonwealth University. His Ph.D. was obtained from the College of William & Mary, with a research focus on comparative immunology and immunopharmacology/toxicology. His work in immunology continued with a post-doctoral fellowship in brain tumor immunology at the Medical College of VA, where he was funded by the American Brain Tumor Association. Prior to Clemson University, Rice was on the research faculty of the College of Veterinary Medicine at Mississippi State University, where he continued in tumor immunology, environmental immunotoxicology, and began his interests in inflammation and its role in chronic diseases. Rice has been funded by NIH, EPA, NOAA, and various Foundations, including present funding from the Self-Regional Healthcare Human Genetics Research Program to investigate the possible role of inflammation in Autism Spectrum Disorders. Rice is recognized as an expert in the generation, development, and application of monoclonal antibodies for novel therapeutic approaches to several diseases impacting human health. Rice has forged numerous collaborative research efforts with scientists at MUSC, GGC, Prisma Health, and within the Clemson University community.

For more information, see his college profile.

How Dr. Rice's research is transforming health care

Research over the last decade has shown a clear role of chronic inflammation in virtually all chronic diseases, including various solid cancers, autoimmune diseases, neurological disorders, and obesity. Rice' research involving the identification of novel anti­inflammatory compounds targeting key cells of the immune system that drive inflammation will make an impact going forward. His ongoing research to develop novel monoclonal antibodies for the treatment and monitoring of chronic inflammatory disorders will be a significant contribution to the rapidly developing field of biological treatments for diseases.

Health Research Expertise Keywords

Brain cancer, chronic inflammation, monoclonal antibodies, comparative immunology, drug discovery, neuro-inflammation, immunopharmacology, toxicology